Bradykinin is a physiologically and pharmacologically active peptide of the kinin group of proteins, consisting of nine amino acids.
CAT# | 10-101-72 |
CAS | 6846-03-3 |
Synonyms/Alias | BK; L-Bradykinin; Callidin I; CallidinI; Callidin-I; KallidinI; Kallidin I; Kallidin-I; C acid; C-acid; Kallidin 9; Kallidin-9; Kallidin9; Bradykinin |
Chemical Name | acetic acid;(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[2-[[(2S)-1-[(2S)-1-[(2S)-2-amino-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carbonyl]pyrrolidine-2-carbonyl]amino]acetyl]amino]-3-phenylpropanoyl]amino]-3-hydroxypropanoyl]pyrrolidine-2-carbonyl]amino]-3-phenylpropanoyl]amino]-5-(diaminomethylideneamino)pentanoic acid |
M.F/Formula | C50H73N15O11·XC2H4O2 |
M.W/Mr. | 1120.3 |
Sequence | One Letter Code: RPPGFSPFR Three Letter Code: H-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg-OH.CH3CO2H |
Application | The pharmacological properties of bradykinin include smooth muscle contraction, vasodilation and hypotension, increase in capillary permeability with edema formation and induction of pain. It induces broncoconstriction in asthmatic subjects and symptoms of rhinitis in nasal provocation. |
Appearance | white fine crystalline powder |
* Please kindly note that our products and services can only be used to support research purposes (Not for clinical use).
Creative Peptides has accumulated a huge library of peptide knowledge including frontier peptide articles, application of peptides, useful tools, and more!
Norleual is a potent inhibitor of the HGF/Met system, which inhibited the prosurvival effects of HGF and suppres ...
PKC (19-36), a synthetic peptide of the pseudosubstrate domain of the kinase, is a selective inhibitor of prote ...
The serine/threonine kinase Pim-1 plays an important role in cell cycle progression and apoptosis inhibition, re ...
Enfuvirtide, also named pentafuside, is an HIV fusion inhibitor originated at Duke University, where researchers ...
Rotigaptide is a novel antiarrhythmic peptide that enhances gap junction (GJ) intercellular conductance between cardiomyocy ...